{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:22:41Z","timestamp":1772781761103,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004043","name":"Kanazawa Medical University","doi-asserted-by":"publisher","award":["S2018-8"],"award-info":[{"award-number":["S2018-8"]}],"id":[{"id":"10.13039\/501100004043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10014-018-0332-1","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T23:19:00Z","timestamp":1543965540000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The clinicopathological analysis of receptor tyrosine kinases in meningiomas: the expression of VEGFR-2 in meningioma was associated with a higher WHO grade and shorter progression-free survival"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3070-8803","authenticated-orcid":false,"given":"Satoko","family":"Nakada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Sasagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Kurose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Shioya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohsuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"332_CR1","unstructured":"Perry A, Louis DN, Budka H, von Deimling A, Sahm F, Rushing EJ, Mawrin C, Claus EB, Loeffler J, Sadetzki S (2016) Meningiomas. WHO Classif. tumours Cent. Nerv. Syst. Revis, 4th edn, pp\u00a0232\u2013245"},{"key":"332_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3171\/2016.11.JNS16913","volume":"128","author":"D Kim","year":"2018","unstructured":"Kim D, Niemierko A, Hwang WL et al (2018) Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. J Neurosurg 128:1123\u20131132. \n                    https:\/\/doi.org\/10.3171\/2016.11.JNS16913","journal-title":"J Neurosurg"},{"key":"332_CR3","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1016\/j.wneu.2017.10.028","volume":"109","author":"JS Ehresman","year":"2018","unstructured":"Ehresman JS, Garzon-Muvdi T, Rogers D et al (2018) The Relevance of Simpson grade resections in modern neurosurgical treatment of World Health Organization Grade I, II, and III meningiomas. World Neurosurg 109:e588\u2013e593. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2017.10.028","journal-title":"World Neurosurg"},{"key":"332_CR4","doi-asserted-by":"publisher","first-page":"dev151019","DOI":"10.1242\/dev.151019","volume":"145","author":"S Karaman","year":"2018","unstructured":"Karaman S, Lepp\u00e4nen V-M, Alitalo K (2018) Vascular endothelial growth factor signaling in development and disease. Development 145:dev151019. \n                    https:\/\/doi.org\/10.1242\/dev.151019","journal-title":"Development"},{"key":"332_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejca.2016.12.004","volume":"73","author":"M Tuchen","year":"2017","unstructured":"Tuchen M, Wilisch-Neumann A, Daniel EA et al (2017) Receptor tyrosine kinase inhibition by regorafenib\/sorafenib inhibits growth and invasion of meningioma cells. Eur J Cancer 73:9\u201321. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2016.12.004","journal-title":"Eur J Cancer"},{"key":"332_CR6","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2018.1.FOCUS17754","volume":"44","author":"S Gupta","year":"2018","unstructured":"Gupta S, Bi WL, Dunn IF (2018) Medical management of meningioma in the era of precision medicine. Neurosurg Focus 44:E3. \n                    https:\/\/doi.org\/10.3171\/2018.1.FOCUS17754","journal-title":"Neurosurg Focus"},{"key":"332_CR7","first-page":"155","volume":"11","author":"DC Allred","year":"1998","unstructured":"Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155\u2013168","journal-title":"Mod Pathol"},{"key":"332_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kaneda","year":"2013","unstructured":"Kaneda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458. \n                    https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"332_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s10014-018-0318-z","volume":"35","author":"V Barresi","year":"2018","unstructured":"Barresi V, Lionti S, Caliri S, Caffo M (2018) Histopathological features to define atypical meningioma: what does really matter for prognosis? Brain Tumor Pathol 35:168\u2013180. \n                    https:\/\/doi.org\/10.1007\/s10014-018-0318-z","journal-title":"Brain Tumor Pathol"},{"key":"332_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.prp.2015.04.015","volume":"211","author":"E Kampmann","year":"2015","unstructured":"Kampmann E, Altendorf-Hofmann A, Gibis S et al (2015) VEGFR2 predicts decreased patients survival in soft tissue sarcomas. Pathol Res Pract 211:726\u2013730. \n                    https:\/\/doi.org\/10.1016\/j.prp.2015.04.015","journal-title":"Pathol Res Pract"},{"key":"332_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10014-010-0012-2","volume":"28","author":"V Barresi","year":"2011","unstructured":"Barresi V (2011) Angiogenesis in meningiomas. Brain Tumor Pathol 28:99\u2013106. \n                    https:\/\/doi.org\/10.1007\/s10014-010-0012-2","journal-title":"Brain Tumor Pathol"},{"key":"332_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/neup.12266","volume":"36","author":"DA Hilton","year":"2016","unstructured":"Hilton DA, Shivane A, Kirk L et al (2016) Activation of multiple growth factor signalling pathways is frequent in meningiomas. Neuropathology 36:250\u2013261. \n                    https:\/\/doi.org\/10.1111\/neup.12266","journal-title":"Neuropathology"},{"key":"332_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/nou148","volume":"17","author":"TJ Kaley","year":"2015","unstructured":"Kaley TJ, Wen P, Schiff D et al (2015) Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neuro Oncol 17:116\u2013121. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nou148","journal-title":"Neuro Oncol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-018-0332-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-018-0332-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-018-0332-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T19:40:03Z","timestamp":1575488403000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-018-0332-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["332"],"URL":"https:\/\/doi.org\/10.1007\/s10014-018-0332-1","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study\u00a0formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}